PATENT CLAIM ANALYSIS

Application Number: 15755435
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "233800"]

Abstract:
The present invention provides a chromone oxime derivative of formula (I), which is a modulator of nervous system receptors sensitive to the neuroexcitatory amino acid glutamate and presents an advantageously high brain exposure upon oral administration, for the treatment or prevention of levodopa-induced dyskinesia. The present invention also provides an improved therapy of Parkinson's disease, using the chromone oxime derivative of formula (I) in combination with ievodopa.

Claim (Index 60):
The method of  claim 55 , wherein said compound of formula (I) or the pharmaceutically acceptable salt, solvate or prodrug thereof and said levodopa or the pharmaceutically acceptable salt, solvate or prodrug thereof are provided in separate pharmaceutical compositions.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15506941', '14113340', '14513488', '11762206', '14702242']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.796905025781152
- 35 USC 102 Novelty (BERT): 0.5847141868600201
- Combined Prediction Score: 0.7756859418890388
- Mean Citation Score: 394.291842
- Max Citation Score: 618.9172
- Similarity Product: 367.18449312841886

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test